CRO Business Operations
Sample data
Resourcing
Utilization, billable hours and capacity by function
Fiscal Year
FY2024
FY2025
FY2026
Therapeutic Area
All
Oncology
Cardiology
Neurology
Immunology
Infectious Disease
Sponsor Type
All
Large Pharma
Mid-size Biotech
Emerging Biotech
Medical Device
Average Utilization
78.2%
Target 80%
Billable FTEs
543
Billable Hours
397,145
Open Capacity (hrs)
107,237
Utilization by Function (%)
Billable FTEs by Function
Billable Hours vs Capacity by Month